Efficacy of direct‐acting antivirals: UK real‐world data from a well‐characterised predominantly cirrhotic HCV cohort

MLA

Stephen T. Barclay, et al. “Efficacy of Direct‐acting Antivirals: UK Real‐world Data from a Well‐characterised Predominantly Cirrhotic HCV Cohort.” Journal of Medical Virology, vol. 91, Aug. 2019, pp. 1979–88. EBSCOhost, https://doi.org/10.1002/jmv.25552.

APA

Stephen T. Barclay, M. Priest, Sumita Verma, G. Abouda, Andrew Fraser, Brendan Healy, Lucia Macken, William Gelson, & William L. Irving. (2019). Efficacy of direct‐acting antivirals: UK real‐world data from a well‐characterised predominantly cirrhotic HCV cohort. Journal of Medical Virology, 91, 1979–1988. https://doi.org/10.1002/jmv.25552

Chicago

Stephen T. Barclay, M. Priest, Sumita Verma, G. Abouda, Andrew Fraser, Brendan Healy, Lucia Macken, William Gelson, and William L. Irving. 2019. “Efficacy of Direct‐acting Antivirals: UK Real‐world Data from a Well‐characterised Predominantly Cirrhotic HCV Cohort.” Journal of Medical Virology 91 (August): 1979–88. doi:10.1002/jmv.25552.